Skip to main content
. 2012 May;129(5):e1301–e1310. doi: 10.1542/peds.2011-3285

TABLE 1.

Characteristics of Included Studies

Study Year Medication Sample Size Design Length of Treatment Mean Age Gender (% Male) JADAD Score Mean Dose (mg/d)
Gordon et al46 1993 Clomipramine (TCA) 12 Crossover 5 wk 10.4 y 57 3 152
McDougle et al47 1996 Fluvoxamine (SSRI) 30 Parallel 12 wk 30.1 y 90 4 277
Remington et al48 2001 Clomipramine (TCA) 36 Crossover 7 wk 16.4 y 83 3 128
Hollander et al49 2005 Fluoxetine (SSRI) 39 Crossover 8 wk 8.2 y 77 3 10.6
King et al50 2009 Citalopram (SSRI) 149 Parallel 12 wk 9.4 y 86 5 16.5
Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders,a NCT0060953135 Active, not recruiting Citalopram (SSRI) 13 Parallel 12 wk 22 y Information not provided 3 18.3
McDougle et al,b unpublished52 Completed Fluvoxamine (SSRI) 34 Parallel 12 wk 5–18 85 UK 106.9
Study of Fluoxetine in Autism (SOFIA),b NCT0051532043 Completed 1/09 Fluoxetine (SSRI) 158 Parallel 14 wk 5–17 y UK UK UK
Study of Fluoxetine in Adults With Autistic Disorder,b NCT0002740444 Completed 10/05 Fluoxetine (SSRI) 48 Parallel 12 wk 18–65 y UK UK UK
Fluvoxamine and Sertraline in Childhood Autism – Does SSRI Therapy Improve Behaviour and/or Mood?b NCT0065517445 Completed 1/07 Fluvoxamine (SSRI) 108 Parallel Children were started on 12.5 mg. If no therapeutic effectiveness was observed after 8 wks, then the child’s dosage could be increased for an additional 8 wk 3–10 y UK UK 12.5
Effectiveness of Early Intervention With Fluoxetine in Enhancing Developmental Processes in Children With Autism,b NCT0018333946 Completed 2/08 Fluoxetine (SSRI) 19 Parallel 12 mo 30–58 mo UK UK 2–20

SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant; UK, unknown.

a

We received trial data in response to our request for relevant data for this trial only.

b

Studies completed but unpublished. Requests were sent to the principal investigators for data associated with each of these trials.